ifosfamide has been researched along with trimethoprim, sulfamethoxazole drug combination in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berchier, MC; Berghmans, T; Florin, MC; Giner, V; Klastersky, J; Koumakis, G; Lafitte, JJ; Lecomte, J; Michel, J; Mommen, P; Ninane, V; Paesmans, M; Sculier, JP; Thiriaux, J; Van Cutsem, O | 1 |
| Abd Algaffar, SO; Khalid, SA; van de Sande, WWJ; Verbon, A | 1 |
1 trial(s) available for ifosfamide and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Endpoint Determination; Etoposide; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Ifosfamide; Lung Neoplasms; Male; Middle Aged; Prognosis; Survival Rate; Time Factors; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vindesine | 2001 |
1 other study(ies) available for ifosfamide and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
Development and validation of a resazurin assay for in vitro susceptibility testing of Actinomadura madurae: a common causative agent of actinomycetoma.
Topics: Amikacin; Amoxicillin; Anti-Bacterial Agents; Ceftriaxone; Ciprofloxacin; Doxycycline; Humans; Ifosfamide; Imipenem; Linezolid; Microbial Sensitivity Tests; Mycetoma; Rifampin; Trimethoprim, Sulfamethoxazole Drug Combination | 2022 |